Semax

Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH), modified for research into neuropeptide signaling. It is discussed in scientific literature for its potential influence on neurotrophic factors, neurotransmitter systems, oxidative-stress pathways, and brain plasticity models. Research remains focused on mechanisms and controlled experimental outcomes rather than consumer wellness claims.

Semax is studied for interactions with neurotrophic and neuromodulatory pathways, including brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), dopaminergic signaling, and inflammatory-response biology. Researchers evaluate how ACTH-derived peptides may influence gene expression, neuronal resilience, and signaling balance in experimental neurological models.

• Neurotrophic-factor expression, including BDNF and NGF-related pathways.
• Cognitive-performance models involving attention, memory, and learning tasks.
• Neuroinflammation, oxidative stress, and neuronal-resilience research.
• Dopamine and serotonin system modulation in experimental settings.
• Stress-response biology and ACTH-fragment peptide signaling.

• Ashmarin IP et al. Semax as a synthetic ACTH fragment with neuroactive properties. Neuroscience and Behavioral Physiology, 1997.
• Dolotov OV et al. Semax effects on the expression of neurotrophins and neurotransmitter-related genes. Molecular Biology, 2006.
• De Wied D and Jolles J. Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects. Physiological Reviews, 1982.